Conversion chemotherapy with capecitabine and oxaliplatin for colorectal cancer with potentially resectable liver metastases: A phase II, open-label, single-arm study.

Li, Yong

Conversion chemotherapy with capecitabine and oxaliplatin for colorectal cancer with potentially resectable liver metastases: A phase II, open-label, single-arm study. [electronic resource] - Journal of cancer research and therapeutics 2018 - 772-779 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study

1998-4138

10.4103/jcrt.JCRT_738_17 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Capecitabine--administration & dosage
Colorectal Neoplasms--pathology
Female
Humans
Liver Neoplasms--diagnosis
Male
Middle Aged
Neoplasm Staging
Organoplatinum Compounds--administration & dosage
Oxaliplatin
Treatment Outcome